Molecular Network Analysis using Reverse Phase Protein Microarrays for Patient Tailored Therapy
The practice of medicine has always aimed at individualized treatment of disease. The relationship between patient and physician has always been a personal one, and the physician's choice of treatment has been intended to be the best fit for the patient's needs. The necessary pooling/grouping of disease families and their assignment to a number of drugs or treatment methods has, consequently, led to an increase in the number of effective therapies. However, given the heterogeneity of most human diseases, and cancer specifically, it is currently impossible for the treating clinician to effectively predict a patient's response and outcome based on current technologies, much less the idiosyncratic resistances and adverse effects associated with the limited therapeutic options.
KeywordsLaser Capture Microdissection Functional Executive Antibody Array Limited Therapeutic Option Amplification Chemistry
Unable to display preview. Download preview PDF.
- Chakravarti, D. N., Chakravarti, B., Moutsatsos, I. (2002) Informatic tools for proteome profiling.Biotechniques Suppl 4–10: 12–5.Google Scholar
- Haab, B. B., Dunham, M. J., and Brown, P. O. (2001) Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol 2(2).Google Scholar
- Humphery-Smith, I., Wischerhoff, E., and Hashimoto, R. (2002) Protein arrays for assessment of target selectivity. Drug Discovery World 4(1), 17–27.Google Scholar
- Macbeath, G. (2002) Protein microarrays and proteomics. Nat Genet. 32 Suppl(526–32).Google Scholar
- Paweletz, C. P., Charboneau, L., Roth, M. J., Bichsel, V. E., Simone, N. L., Chen, T., Han, N., Gillespie, J. W., Emmert-Buck, M., Petricoin, E. F., and Liotta, L. A. (2001) Reverse phase proteomic microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene. Apr 12;20(16), 1981–9.PubMedCrossRefGoogle Scholar
- Shankavaram, U. T., Reinhold, W. C., Nishizuka, S., Major, S., Morita, D., Chary, K. K., Reimers, M. A., Scherf, U., Kahn, A., Dolginow, D., Cossman, J., Kaldjian, E. P., Scudiero, D. A., Petricoin, E., Liotta, L., Lee, J. K., Weinstein, J. N. (2007) Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol Cancer Ther. Mar 5.Google Scholar
- Sjoblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., Szabo, S., Buckhaults, P., Farrell, C., Meeh, P., Markowitz, S. D., Willis, J., Dawson, D., Willson, J. K., Gazdar, A. F., Hartigan, J., Wu, L., Liu, C., Parmigiani, G., Park, B. H., Bachman, K. E., Papadopoulos, N., Vogelstein, B., Kinzler, K. W., Velculescu, V. E. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314(5797), 268–74.PubMedCrossRefGoogle Scholar